Catalysts 2019, 9, x; doi: FOR PEER REVIEW www.mdpi.com/journal/catalysts 1. Tables   Table S1 . The yields of myricetin-7-O-glucuronide (M7GA) and the solubilities of myricetin or M7GA obtained in the modified M9 reaction system containing different concentrations of organic solvents. The yield of M7GA obtained in the reaction system containing organic solvents relative to the one obtained in the reaction system without organic solvents (control group). b The solubility of myricetin obtained in the modified M9 medium containing organic solvents relative to the one obtained in the modified M9 medium (control).
No. Solvents
c The solubility of M7GA obtained in the modified M9 medium containing organic solvents relative to the one obtained in the modified M9 medium (control). Table S3 . Concentrations of proteins released from E. coli BPGUT cells after being exposed to organic solvents for 6h.
a The content of extracellular proteins leaked from the organic solvents-treated cells relative to the one leaked from the untreated cells (control group). Table S4 . Concentrations of proteins released from E. coli BPGUT cells after being exposed to organic solvents for 12 h. a The content of extracellular proteins leaked from the organic solvents-treated cells relative to the one leaked from the untreated cells (control group). Figure S4 . Concentrations of proteins released from E. coli BPGUT cells after the cells were exposed to 2% (v/v), 5% (v/v), 10% (v/v) and 20% (v/v) acetone, DMF, DMSO, EtOH, and MeOH for 12 h, respectively. Figure S5 . Time course for the production of myricetin-7-O-glucuronide (M7GA) obtained in a 100-mL shake-flask system containing 10 mL of whole-cell catalyst. Myricetin solid powder (6.36 mg) or stock solution (100 mM, dissolved in DMSO) was added to the above whole-cell biocatalyst system to form a working concentration of 2 mmol/L, which was then kept shaking at 30 °C for 24 h.
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